financetom
Business
financetom
/
Business
/
Nexstar Media Group Insider Sold Shares Worth $2,328,879, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nexstar Media Group Insider Sold Shares Worth $2,328,879, According to a Recent SEC Filing
Nov 12, 2024 11:08 PM

01:12 PM EST, 11/12/2024 (MT Newswires) -- Perry A Sook, Director, Chief Executive Officer, on November 07, 2024, sold 12,239 shares in Nexstar Media Group ( NXST ) for $2,328,879. Following the Form 4 filing with the SEC, Sook has control over a total of 1,650,650 shares of the company, with 674,694 shares held directly and 975,956 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1142417/000095017024125030/xslF345X05/ownership.xml

Price: 167.65, Change: -3.36, Percent Change: -1.96

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amentum Fiscal Q4 Non-GAAP Net Income, Revenue Decline; Sets Fiscal 2025 Guidance
Amentum Fiscal Q4 Non-GAAP Net Income, Revenue Decline; Sets Fiscal 2025 Guidance
Dec 16, 2024
05:14 PM EST, 12/16/2024 (MT Newswires) -- Amentum (AMTM) reported fiscal Q4 pro forma non-GAAP net income late Monday of $0.47 per diluted share, down from $0.59 a year earlier. Analysts polled by FactSet expected $0.33. Revenue for the quarter ended Sept. 27 was $3.57 billion, down from $3.60 billion a year earlier. Analysts surveyed by FactSet expected $3.41 billion....
Merck discontinues development of 2 experimental cancer drugs after trial failures
Merck discontinues development of 2 experimental cancer drugs after trial failures
Dec 16, 2024
Dec 16 (Reuters) - Merck ( MRK ) said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several trials. The pharmaceutical giant's decision comes after several setbacks for the drugs, vibostolimab and favezelimab, which were being tested separately in combination with its top-selling drug Keytruda for various forms of cancer. On Monday,...
Enghouse Acquires AI Software Company Aculab PLC
Enghouse Acquires AI Software Company Aculab PLC
Dec 16, 2024
05:13 PM EST, 12/16/2024 (MT Newswires) -- Enghouse Systems ( EGHSF ) , after trading Monday said its U.K. unit acquired Aculab PLC, a provider of on-premise and cloud based communications and AI software, for an undisclosed price. Aculab products include a communications platform as a service (CPaaS), an AI-driven answering machine detection, advanced voice and face biometrics technologies, as...
GEO Group Unveils $70 Million CapEx to Expand Services; Plans to Reduce Debt
GEO Group Unveils $70 Million CapEx to Expand Services; Plans to Reduce Debt
Dec 16, 2024
05:13 PM EST, 12/16/2024 (MT Newswires) -- GEO Group ( GEO ) said late Monday it plans to invest $70 million to strengthen its capabilities to deliver expanded detention capacity, secure transportation, and electronic monitoring services to US Immigration and Customs Enforcement. The company said it intends to pursue a possible sale of underperforming company-owned state correctional facilities to offset...
Copyright 2023-2026 - www.financetom.com All Rights Reserved